DENVER, Oct. 14, 2015 /PRNewswire/ -- After 10 years and over $10 million of research at the University of Colorado, funded by the National Institutes of Health, ProTechSure Scientific, Inc. will introduce DIFINSA53™ Skin Protectant Lotion at the 2015 Annual Convention of the American Society for Radiation Oncology (ASTRO) in San Antonio, TX.
DIFINSA53™ Skin Protectant Lotion is the result of research and development conducted by a multidisciplinary team of scientists and doctors of oncology, dermatology and pharmacology at the University of Colorado Anschutz Medical Center.
DIFINSA53™ lotion contains ingredients that are supported by over 40 scientific publications. As an over-the-counter medication, the lotion's natural botanical ingredients penetrate the surface of the skin via state-of-the-art micro technology. The active skin protectant in DIFINSA53™ lotion is a silicone fluid called dimethicone 1%. Widely used in cosmetics, dimethicone is generally regarded as safe by the U.S. Food and Drug Administration, and is clinically-proven to be non-irritating to the skin1,2,3.
Specifically formulated for skin exposed to radiation, DIFINSA53™ Skin Protectant Lotion temporarily protects and relieves chafed, chapped or cracked skin, and promotes patient compliance during radiation therapy. DIFINSA53™ lotion calms, soothes and hydrates the skin with a non-greasy, fast absorbing formula that exhibits a light, pleasant aroma.
In support of the product's introduction, an off-the-shelf professional program includes a counter top display to help dispense sample tubes of Difinsa™53 lotion in the doctor's office, along with Brief Directions for Use, patient brochures and downloadable instructions, located on the product's website: www.difinsa53.com.
About ProTechSure Scientific. Inc.
ProTechSure Scientific, Inc. was founded by CU physicians and research scientists to commercialize university-based research. The company develops and markets medical products that prevent and treat skin disorders. Dedicated to improving the quality of life for its customers, ProTechSure Scientific utilizes rigorous medical evidence and adheres to the highest ethical and FDA standards.
1 Becker LC et al. Safety assessment of dimethicone crosspolymers as used in cosmetics. Int J Toxicol 2014 May/June; 33 (2): Suppl 65S-115S.
2 Nair B. Final report on the safety assessment of stearoxy dimethicone. Int J Toxicol 2003; 22 Suppl 2: 11-35.
3 Raposo S et al. Safety assessment and biological effects of a new cold processed silemulsion for dermatogolical purpose. Biomed Res Int. 2013; 2013: 181634. Published online 2013 Nov 5: http://dx.doi.org/10.1155/2013/181634.
SOURCE ProTechSure Scientific. Inc.